1.17
price up icon6.36%   0.07
after-market アフターアワーズ: 1.17
loading

Akoya Biosciences Inc (AKYA) 最新ニュース

pulisher
Apr 17, 2025

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders - Business Wire

Apr 17, 2025
pulisher
Apr 15, 2025

Akoya Biosciences (NASDAQ:AKYA) Given New $1.65 Price Target at Piper Sandler - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Tikvah Management Calls on Quanterix to Explain the Egregious Te - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Bluefield Daily Telegraph

Apr 14, 2025
pulisher
Apr 14, 2025

Quanterix Faces Investor Backlash: $30M Convertible Notes Deal Under Fire - Stock Titan

Apr 14, 2025
pulisher
Apr 09, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Apr 09, 2025
pulisher
Apr 07, 2025

Akoya Biosciences stock hits 52-week low at $1.07 amid market challenges By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Akoya Biosciences stock hits 52-week low at $1.07 amid market challenges - Investing.com India

Apr 07, 2025
pulisher
Apr 07, 2025

Quanterix Under Fire: Top Investor Warns of 'Value Destructive' $30M Deal with Struggling Akoya - Stock Titan

Apr 07, 2025
pulisher
Apr 04, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.

Apr 04, 2025
pulisher
Apr 04, 2025

Akoya BiosciencesOn April 2, Entered Securities Purchase Agreement With Quanterix Corporation - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Spatial Genomics and Transcriptomics Industry Analysis Report 2025, Featuring Detailed Profiles of Leading Players10x Genomics, Bruker Corp., Akoya Biosciences, and Bio-Techne Among OthersResearchAndMarkets.com - Bluefield Daily Telegraph

Apr 04, 2025
pulisher
Apr 02, 2025

Akoya Biosciences and Team SAMBAI Announce Selection of the - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Akoya Biosciences And Team SAMBAI Select PhenoCycler-Fusion For Cancer Equity Research - Nasdaq

Apr 02, 2025
pulisher
Apr 02, 2025

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities - Yahoo Finance

Apr 02, 2025
pulisher
Mar 31, 2025

Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Decreases By 30.8% - The AM Reporter

Mar 31, 2025
pulisher
Mar 30, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Down 30.8% in March - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Akoya Biosciences stock hits 52-week low at $1.39 amid market challenges - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Akoya Biosciences’ (AKYA) Equal Weight Rating Reaffirmed at Stephens - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Akoya Biosciences Shares Fall After Downgrade From Stephens - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

This Brown & Brown Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Mar 25, 2025
pulisher
Mar 25, 2025

Stephens Downgrades Akoya Biosciences to Equalweight From Overweight, Price Target is $1.80 - Marketscreener.com

Mar 25, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah to oppose Quanterix-Akoya Biosciences merger - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix’s Proposed Merger with Akoya Biosciences - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Marketscreener.com

Mar 24, 2025
pulisher
Mar 24, 2025

Key Investor Fights Back: Quanterix Merger Under Fire Over Valuation Concerns - Stock Titan

Mar 24, 2025
pulisher
Mar 24, 2025

Akoya Biosciences (AKYA) to Release Quarterly Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 20, 2025

Akoya Biosciences Reports 2024 Financial Results - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Stephens Reaffirms “Overweight” Rating for Akoya Biosciences (NASDAQ:AKYA) - The AM Reporter

Mar 20, 2025
pulisher
Mar 19, 2025

Akoya Biosciences (NASDAQ:AKYA) Receives Overweight Rating from Stephens - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Akoya Biosciences Shares Down 6.4% After Stock Offering… -June 08, 2023 at 10:10 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya Biosciences stock hits 52-week low at $1.43 amid market challenges - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

Akoya: Q4 Earnings Snapshot - Milford Mirror

Mar 18, 2025
pulisher
Mar 17, 2025

Akoya Biosciences earnings missed by $0.01, revenue topped estimates - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. Q4 Loss Decreases, But Misses Estimates - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences, Inc. SEC 10-K Report - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake urges Quanterix to address questions regarding Akoya deal -March 17, 2025 at 04:28 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Amid Pending Acquisition by Quanterix Corporation - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Quanterix Merger Under Fire: Top Investor Reveals Shocking 82% Value Disparity - Stock Titan

Mar 17, 2025
pulisher
Mar 17, 2025

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call - Bluefield Daily Telegraph

Mar 17, 2025
pulisher
Mar 15, 2025

Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Brokerages - Defense World

Mar 15, 2025
pulisher
Mar 11, 2025

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger -March 11, 2025 at 10:40 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Quanterix Merger Under Fire: 7.25% Stakeholder Reveals Shocking Valuation Concerns - StockTitan

Mar 11, 2025
$64.94
price up icon 1.56%
$173.87
price up icon 0.96%
$58.19
price up icon 2.20%
medical_instruments_supplies BAX
$28.62
price up icon 0.28%
medical_instruments_supplies WST
$215.13
price up icon 4.49%
medical_instruments_supplies COO
$79.79
price up icon 1.39%
大文字化:     |  ボリューム (24 時間):